Literature DB >> 5234350

L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia.

J M Hill, J Roberts, E Loeb, A Khan, A MacLellan, R W Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5234350

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  55 in total

Review 1.  Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia.

Authors:  Xavier Thomas; Caroline Le Jeune
Journal:  Int J Hematol Oncol       Date:  2016-05-05

2.  Metabolic engineering generates a transgene-free safety switch for cell therapy.

Authors:  Volker Wiebking; James O Patterson; Renata Martin; Monica K Chanda; Ciaran M Lee; Waracharee Srifa; Gang Bao; Matthew H Porteus
Journal:  Nat Biotechnol       Date:  2020-07-13       Impact factor: 54.908

Review 3.  Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

Authors:  A H Chalmers; L A Burgoyne; A W Murray
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 4.  Cancer chemotherapy--the first twenty-five years.

Authors:  R B Scott
Journal:  Br Med J       Date:  1970-10-31

5.  [Increase of immunoglobulins and formation of antibodies in the course of asparaginase treatment].

Authors:  R Lamerz; A Fateh-Moghadam; B Hornung; H Ehrhart
Journal:  Klin Wochenschr       Date:  1971-03-15

Review 6.  [L-asparaginase and leukemia].

Authors:  E Grundmann
Journal:  Klin Wochenschr       Date:  1969-01-15

7.  [Inhibition of malignant human neoplasms with L-asparaginase].

Authors:  H F Oettgen; H K Schulten
Journal:  Klin Wochenschr       Date:  1969-01-15

8.  Production of L-asparaginase II by Escherichia coli.

Authors:  H Cedar; J H Schwartz
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

9.  GCN2 is required to increase fibroblast growth factor 21 and maintain hepatic triglyceride homeostasis during asparaginase treatment.

Authors:  Gabriel J Wilson; Brittany A Lennox; Pengxiang She; Emily T Mirek; Rana J T Al Baghdadi; Michael E Fusakio; Joseph L Dixon; Gregory C Henderson; Ronald C Wek; Tracy G Anthony
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-09       Impact factor: 4.310

10.  GCN2 protein kinase is required to activate amino acid deprivation responses in mice treated with the anti-cancer agent L-asparaginase.

Authors:  Piyawan Bunpo; Allison Dudley; Judy K Cundiff; Douglas R Cavener; Ronald C Wek; Tracy G Anthony
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.